These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 17658412)
21. A relational database for diagnosis of hematopoietic neoplasms using immunophenotyping by flow cytometry. Nguyen AN; Milam JD; Johnson KA; Banez EI Am J Clin Pathol; 2000 Jan; 113(1):95-106. PubMed ID: 10631862 [TBL] [Abstract][Full Text] [Related]
22. More than just quality control. Carey JL; Oldaker TA Clin Lab Med; 2007 Sep; 27(3):687-707, ix. PubMed ID: 17658413 [TBL] [Abstract][Full Text] [Related]
23. Clinical Cytometry on both sides of the Atlantic, 2011. Preffer FI; Gratama JW Cytometry B Clin Cytom; 2011 Nov; 80(6):373-4. PubMed ID: 22002905 [No Abstract] [Full Text] [Related]
24. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations. Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C; Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010 [TBL] [Abstract][Full Text] [Related]
25. Twenty years of external quality assurance in clinical cell analysis--a tribute to Jean-Luc D'Hautcourt. Brando B; Gatti A; Chianese R; Gratama JW Cytometry B Clin Cytom; 2007 Jan; 72(1):2-7. PubMed ID: 17177196 [TBL] [Abstract][Full Text] [Related]
26. Flow cytometric determination of residual white blood cell levels in preserved samples from leukoreduced blood products. Palmer DS; Birch P; O'Toole J; Henderson D; Scalia V Transfusion; 2008 Jan; 48(1):118-28. PubMed ID: 17900282 [TBL] [Abstract][Full Text] [Related]
27. External quality assurance schemes in flow cytometry. Liu TC Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 2():91-3. PubMed ID: 12755276 [TBL] [Abstract][Full Text] [Related]
28. Immunophenotypic characterization of CD34(pos) cells. Keeney M; Brown W; Gratama J; Papa S; Lanza F; Sutherland DR; J Biol Regul Homeost Agents; 2003; 17(3):254-60. PubMed ID: 14524611 [No Abstract] [Full Text] [Related]
29. The role of flow cytometry in companion animal diagnostic medicine. Tarrant JM Vet J; 2005 Nov; 170(3):278-88. PubMed ID: 16266842 [TBL] [Abstract][Full Text] [Related]
30. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Calvelli T; Denny TN; Paxton H; Gelman R; Kagan J Cytometry; 1993 Oct; 14(7):702-15. PubMed ID: 8243200 [No Abstract] [Full Text] [Related]
31. Total nucleated cell differential for blood and bone marrow using a single tube in a five-color flow cytometer. Björnsson S; Wahlström S; Norström E; Bernevi I; O'Neill U; Johansson E; Runström H; Simonsson P Cytometry B Clin Cytom; 2008 Mar; 74(2):91-103. PubMed ID: 18061952 [TBL] [Abstract][Full Text] [Related]
32. A decision-support system for flow cytometry immunophenotyping. Asare AL; Ellis JS; Caldwell CW Am J Clin Pathol; 2002 Oct; 118(4):567-73. PubMed ID: 12375644 [TBL] [Abstract][Full Text] [Related]
33. Clinical flow cytometry: a transition in utilization. Goolsby CL; Paniagua M; Marszalek L Cancer Treat Res; 2004; 121():239-57. PubMed ID: 15217213 [No Abstract] [Full Text] [Related]
34. Automated immunostaining of cell smears: an alternative to flow cytometry. Happerfield LC; Saward R; Grimwade L; Bloxham D; Erber WN J Clin Pathol; 2008 Jun; 61(6):740-3. PubMed ID: 18326018 [TBL] [Abstract][Full Text] [Related]
35. In the realm for standardization in immunophenotyping. Tárnok A Cytometry A; 2012 Nov; 81(11):931-2. PubMed ID: 23090894 [No Abstract] [Full Text] [Related]
36. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: recommendations for training and education to perform clinical flow cytometry. Greig B; Oldaker T; Warzynski M; Wood B Cytometry B Clin Cytom; 2007; 72 Suppl 1():S23-33. PubMed ID: 17803190 [TBL] [Abstract][Full Text] [Related]
37. Quality control of flow cytometric immunophenotyping of haematological malignancies. Gratama JW; Bolhuis RL; Van 't Veer MB Clin Lab Haematol; 1999 Jun; 21(3):155-60. PubMed ID: 10448596 [TBL] [Abstract][Full Text] [Related]
38. From research tool to routine test: CD38 monitoring in HIV patients. Coetzee LM; Tay SS; Lawrie D; Janossy G; Glencross DK Cytometry B Clin Cytom; 2009 Nov; 76(6):375-84. PubMed ID: 19422053 [TBL] [Abstract][Full Text] [Related]
39. Guidelines on the use of multicolour flow cytometry in the diagnosis of haematological neoplasms. British Committee for Standards in Haematology. Johansson U; Bloxham D; Couzens S; Jesson J; Morilla R; Erber W; Macey M; Br J Haematol; 2014 May; 165(4):455-88. PubMed ID: 24620735 [No Abstract] [Full Text] [Related]
40. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Kalina T; Flores-Montero J; van der Velden VH; Martin-Ayuso M; Böttcher S; Ritgen M; Almeida J; Lhermitte L; Asnafi V; Mendonça A; de Tute R; Cullen M; Sedek L; Vidriales MB; Pérez JJ; te Marvelde JG; Mejstrikova E; Hrusak O; Szczepański T; van Dongen JJ; Orfao A; Leukemia; 2012 Sep; 26(9):1986-2010. PubMed ID: 22948490 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]